September 18, 2019

Paper Published in Leukemia Research

By msequeira

Congratulations to Leslie Andritsos, MD!

Dr. Andritsos and her colleagues at other institutions recently published a study in Leukemia Research entitled Clinical and cost outcomes of pre-emptive plerixafor administration in patients with multiple myeloma undergoing stem cell mobilization.

The study found that giving the stem cell mobilization agent plerixafor pre-emptively enhanced collection efficiency and resulted in more than $10,000 in cost savings, compared with standard administration of the drug.

Tags: In the Media